👆👆👆👆👆👆👆👆Suggestion :- BUY IF PRICE COMES AGAIN AT 316 WITH SL OF 314 FOR TARGET OF 325
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
TORNTPHARM Share Price Discussion
Torrent Pharmaceuticals Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
TORNTPHARM Long Term Analysts Rating
- ★★
- ★★
- ★★
- ★★
- ★★
3.9/5 (15 Ratings)
TORNTPHARM Share Price *
1,998.4 -21.75 (-1.08%)
* (quote may be delayed)
Find answers to all your questions on live TORNTPHARM message board: Is TORNTPHARM buy or sell? Should I buy TORNTPHARM shares? Why are TORNTPHARM shares falling? Should I invest in TORNTPHARM stock?
You can also check TORNTPHARM share price target recommended by brokerages.
TORNTPHARM Discussion Forum
@piyushrawtani • Reputation: 392
#torrentpharma , at ATHs , h&s top in a bull trend,powerful .
Like
reply
Reply
@ShoyabHafeji • Reputation: 1,542
HALAL INVESTMENT in TORNTPHARMTORRENT PHARMA 1515 TO 1967
2028
Like
reply
Reply
@thekingofequity • Reputation: 678
My view on Torrent Power
Cmp @ 313 spot
Tgt 320-327-335++
Best buy @ 301-296
SL @ YOUR OWN RISK or PING ME
Reminder @
If break and sustain/close above 335 than showing more strength for tgt 340-348-360++
But Major Resistance @ 365
Like
reply
Reply
@ShoyabHafeji • Reputation: 1,542
HALAL INVESTMENT in TORNTPHARMTORRENT PHARMA...1515 BUY RANGE...1495 TO 1475 ...
TORRENT PHARMA 1515 TO 1967
Like
reply
Reply
@ravikanthchopperla • Reputation: 10,669
Torrent Pharmaceuticals The company said it will consider fundraising on January 27 by issue of equity shares including convertible bonds/debentures through QIP and/or depository receipts or any other modes. The stock advanced 1.4%.
Like
reply
Reply
@stocktrendr • Reputation: 143
Torrent Pharma: Board will consider raising funds via equity on January 27
Like
reply
Reply
@mohammedhossain • Reputation: 22,084
TORNTPHARM
INTRADAY BUY TORNTPH AROUND 1903-1905,SL-1885,TRGT-1935
Like
reply
Reply (2)
Latest replies
@HarmonicsTraders • Reputation: 1,226
Reversal day for TORNTPHARM is Jan 22 based on Gann Maths method
Like
reply
Reply
@mohammedhossain • Reputation: 22,084
INTRADAY CALL UPDATE : BOOK PART PROFITS IN TORNTPH AROUND 1870-1874 REC OBUY AT 1862
Like
reply
Reply
@mohammedhossain • Reputation: 22,084
SHORT TERM DELIVERY - TORNTPHARMA @1805-1817 SL 1774 TGT 1870 MAX DURATION 10 DAYS
Like
reply
Reply (1)
Latest replies
TORNTPHARMA TGT DONE @1870 BOOK HUGH PROFIT
@tradingfab • Reputation: 720
18-12-19
TORNTPHARM BUY FUT DEC (Intraday)
only above @ 1825
Like
reply
Reply (5)
Latest replies
LTP 1826 🔥🔥
LTP 1826.65 🔥🔥
Hit 1828.70 💥💥🔥🔥
Hit 1831 💥💥🔥🔥
LTP 1833.10 💥💥🔥🔥
@tradewithprobabi... • Reputation: 16
tradewithprobabilies in TORNTPHARMTorrentpharma cash support @1825-1820
New high 1854 book profit here
Like
reply
Reply
@tradewithprobabi... • Reputation: 16
tradewithprobabilies in TORNTPHARMTorrentpharma cash support @1825-1820
Made high 1844 from 1827
Like
reply
Reply
@RISHABHTYAGI • Reputation: 4,493
RJ ROCKET TRADES in TORNTPHARM*BTST BUY TORRENT PHARMA* *CASH ONLY CMP 1792* ...
*BTST SUPER DUPER HIT GUYS*
*TORRENT PHARMA 50 POINTS UP FROM OUR BUY LEVEL*
Like
reply
Reply
@RISHABHTYAGI • Reputation: 4,493
RJ ROCKET TRADES in TORNTPHARM*BTST BUY TORRENT PHARMA* *CASH ONLY CMP 1792* ...
*torrent pharma ready to* *break 1800+++ level guys*
*then 1820 coming up*
Like
reply
Reply
@RISHABHTYAGI • Reputation: 4,493
*BTST BUY TORRENT PHARMA*
*CASH ONLY CMP 1792*
*TG 1810/1815/1820*
*SL 1778*
Like
reply
Reply
@ravikanthchopperla • Reputation: 10,669
NSEI Block Deal TORRENT PHARMA 40,642 shares at 1724.75 INR
22-Nov-2019 02:07:35 PM
1
reply
Reply
@100billionclub • Reputation: 3,836
HARMONIC: 1ST TGT ACHIEVED IN TORNTPHARMA @ 1730, PROFIT RS 37500.
Like
reply
Reply
@databot • Reputation: 1,317
Sharekhan Recommendation on TORNTPHARM
Date: 23-Oct-19
Broker: Sharekhan
Price @ Call: 1669.88
Target: 1720
Recommendation: HOLD
Like
reply
Reply
@databot • Reputation: 1,317
Sharekhan Recommendation on TORNTPHARM
Date: 23-Oct-19
Broker: Sharekhan
Price @ Call: 1669.88
Target: 1720
Recommendation: HOLD
Like
reply
Reply
@databot • Reputation: 1,317
ICICIdirect.com Recommendation on TORNTPHARM
Date: 24-Oct-19
Broker: ICICIdirect.com
Price @ Call: 1757.84
Target: 2020
Recommendation: BUY
Like
reply
Reply
@newsbot • Reputation: 1,933
Torrent Pharma up 4% on robust Q2 result
The share touched its 52-week high Rs 1,964 and 52-week low Rs 1,453 on 29 March, 2019 and 23 July, 2019, respectively.
The share touched its 52-week high Rs 1,964 and 52-week low Rs 1,453 on 29 March, 2019 and 23 July, 2019, respectively.
Moneycontrol
Like
reply
Reply
@pyramidstock • Reputation: 2,205
Torrrenpharam BTST Cmp 1680 Sl 1655
Result after market
1
reply
Reply (1)
Latest replies
1758 enjoy and book
@nishantshah91 • Reputation: 3,299
UBS downgrades Torrent Pharma to Sell from Neutral, TP 1500 from 1800
Goldman Sachs downgrades Ashok Leyland to Neutral from Buy, TP 84 from 87
BofA ML upgrades DLF to Buy from Underperform, TP 196 from 179
Morgan Stanley upgrades Shree Cement to OW from EW, TP 22000 from 19270
Like
reply
Reply
@kingharry • Reputation: 1,533
Stock Update: SELL TORRENT PHARMA @ 1653 WITH SL 1675
TGT OPEN
Like
reply
Reply
@newsbot • Reputation: 1,933
Taking Stock: Volatile Wednesday! Time to book profits and buy at lower levels?
The short term momentum indicators are overbought and hence some consolidation is playing out.
The short term momentum indicators are overbought and hence some consolidation is playing out.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Torrent Pharma Q2 PAT seen up 8% YoY to Rs. 220.3 cr: Emkay
Net Sales are expected to increase by 9.4 percent Y-o-Y (up 2.5 percent Q-o-Q) to Rs. 2,073 crore, according to Emkay.
Net Sales are expected to increase by 9.4 percent Y-o-Y (up 2.5 percent Q-o-Q) to Rs. 2,073 crore, according to Emkay.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Stocks in the news: Infosys, Avenue Supermart, BoB, NMDC, Cadila Health, HUL
Avenue Supermarts | NMDC | Jain Irrigation | Infosys and Cadila Healthcare are stocks, which are in news today.
Avenue Supermarts | NMDC | Jain Irrigation | Infosys and Cadila Healthcare are stocks, which are in news today.
Moneycontrol
Like
reply
Reply
@databot • Reputation: 1,317
Reliance Securities Recommendation on TORNTPHARM
Date: 11-Oct-19
Broker: Reliance Securities
Price @ Call: 1690.1
Target: 1740
Recommendation: HOLD
Like
reply
Reply
@suremeanssure • Reputation: 176
TORRENTPHARMA BUY NSE CASH AT CMP 1687 TARGET 1697 - 1710
Like
reply
Reply
@newsbot • Reputation: 1,933
In September quarter earnings season, brokerages bet on these 15 midcap stocks
Banking (ICICI Bank, Axis Bank and SBI) , building materials, pharmaceuticals and consumer companies are likely to deliver decent results in the September quarter, say experts.
Banking (ICICI Bank, Axis Bank and SBI) , building materials, pharmaceuticals and consumer companies are likely to deliver decent results in the September quarter, say experts.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Torrent Pharmaceuticals slips 6% on warning letter from USFDA
The company does not believe that the warning letter will disrupt supplies or impact the revenue of its Indrad facility.
The company does not believe that the warning letter will disrupt supplies or impact the revenue of its Indrad facility.
Moneycontrol
Like
reply
Reply
@giant • Reputation: 0
INTRADAY SELL TORNTPHARM
EN1: 1650-1655|SL-5000RS
EN2: 1690-1695|SL-5000RS
TGT-1500
This call is based on future price and if you are checking in cash price may differ. For more details and trade with us search on telegram for gianttrade or call on +91-7-8-8-7-8-8-7-8-8-6
Like
reply
Reply
@newsbot • Reputation: 1,933
Market Headstart: Nifty seen opening lower; Bharti Airtel, Axis Bank top buys
Trends on SGX Nifty indicate a negative opening for the broader index in India, with a 51 points loss or 0.45 percent. Nifty futures were trading around 11,287-level on the Singaporean Exchange.
Trends on SGX Nifty indicate a negative opening for the broader index in India, with a 51 points loss or 0.45 percent. Nifty futures were trading around 11,287-level on the Singaporean Exchange.
Moneycontrol
Like
reply
Reply
@mytradepicks00 • Reputation: 8
Torrent Pharma PE will work
1640 PE @35, expected to cross 50 today...
Like
reply
Reply (1)
Latest replies
Gap Down 6% 😂
@mytradepicks00 • Reputation: 8
Mostly Torrent Pharma will fall Minimum 5% today...
Let's see
Like
reply
Reply
@newsbot • Reputation: 1,933
Stocks in the news: Torrent Pharma, Bharti Airtel, Union Bank, Century Tex, Vimta Labs
Bharti Airtel | Torrent Pharma | Transformers & Rectifiers | Rama Steel and Bank of Maharashra are stocks which are in news today.
Bharti Airtel | Torrent Pharma | Transformers & Rectifiers | Rama Steel and Bank of Maharashra are stocks which are in news today.
Moneycontrol
Like
reply
Reply
- NewsBotOct 24 5:23 PMTorrent Pharma up 4% on robust Q2 resultMoneycontrolNewsBotOct 16 10:13 PMTaking Stock: Volatile Wednesday! Time to book profits and buy at lower levels?MoneycontrolNewsBotOct 14 9:53 PMTorrent Pharma Q2 PAT seen up 8% YoY to Rs. 220.3 cr: EmkayMoneycontrolNewsBotOct 14 1:53 PMStocks in the news: Infosys, Avenue Supermart, BoB, NMDC, Cadila Health, HULMoneycontrolNewsBotOct 10 6:48 PMIn September quarter earnings season, brokerages bet on these 15 midcap stocksMoneycontrolNewsBotOct 10 4:53 PMTorrent Pharmaceuticals slips 6% on warning letter from USFDAMoneycontrolNewsBotOct 10 2:33 PMMarket Headstart: Nifty seen opening lower; Bharti Airtel, Axis Bank top buysMoneycontrolNewsBotOct 10 1:48 PMStocks in the news: Torrent Pharma, Bharti Airtel, Union Bank, Century Tex, Vimta LabsMoneycontrolNewsBotOct 10 1:13 AM
Torrent Pharma gets warning letter from USFDA for Gujarat facilityMoneycontrolNewsBotSep 23 1:58 PM
Stocks in the news: Biocon, Petronet LNG, Hero Moto, Alkem Lab, PNB, Cipla, Torrent PharmaMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.